Clinical Trials Directory

Trials / Completed

CompletedNCT03975075

Biofeedback Treatment of Anxiety Associated With Chronic Spinal Cord Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Craig Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to test the feasibility of an intervention using biofeedback to treat stress and anxiety among individuals with tetraplegia. The expected duration of participation in this study is about 5 hours over the course of about 5 weeks. Participants will be randomly assigned to either a biofeedback training intervention or a control group. After completing questionnaires, participants will undergo physiological monitoring for the purpose of measuring heart rate and breathing. Those assigned to the biofeedback group will undergo 20 minutes of physiological monitoring while also participating in biofeedback training twice a week for 4 weeks (8 sessions) from home. Those assigned to the control group will undergo 20 minutes of physiological monitoring twice a week for 4 weeks (8 sessions) from home, but will not receive biofeedback training. Each session is expected to last 30 minutes to allow for completion of questionnaires over the the phone prior to and following each training session. It is hypothesized that the biofeedback intervention will demonstrate high feasibility and compared to those in the control group, participants who receive the biofeedback intervention will attain greater pre-post reductions in both physiological and self-reported stress.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPsychophysiological monitoring30 minutes of one channel (ECG) physiological monitoring with Mindfield eSense Pulse.
BEHAVIORALBiofeedback trainingTraditional resonance frequency training with the Mindfield eSense Pulse smartphone application. Using visual feedback of real time parameters of HRV and the use of controlled breathing, participants are trained to reach a relaxed state.

Timeline

Start date
2019-10-01
Primary completion
2023-01-31
Completion
2023-01-31
First posted
2019-06-05
Last updated
2024-08-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03975075. Inclusion in this directory is not an endorsement.